ANTI-VIRAL TREATMENT OF CHRONIC HEPATITIS C IN A PAEDIATRIC POPULATION: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Mernagh, P. [1 ]
Norris, S. [2 ]
Del Cuore, M. [3 ]
机构：
[1] Hlth Technol Analysts, Lilyfield, NSW, Australia
[2] Hlth Technol Analysts, Sydney, NSW, Australia
[3] Merck Sharp & Dohme Ltd, Sydney, NSW, Australia
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.935
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A403 / A403
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
    Guvenc Kockaya
    Akin Kose
    Fatma Betul Yenilmez
    Oktay Ozdemir
    Ece Kucuksayrac
    [J]. Cost Effectiveness and Resource Allocation, 13
  • [2] Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
    Kockaya, Guvenc
    Kose, Akin
    Yenilmez, Fatma Betul
    Ozdemir, Oktay
    Kucuksayrac, Ece
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [3] Cost-effectiveness of growth factors during hepatitis C anti-viral therapy
    Chapko, M. K.
    Dominitz, J. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (07) : 1067 - 1077
  • [4] Cost-effectiveness analysis of anti-viral treatments in patients with chronic hepatitis B infection in Hong Kong
    Lam, T. P. Elegance
    Lam, Cindy L. K.
    Lai, C. L.
    Yuen, M. F.
    McGhee, Sarah
    Fong, Daniel
    Leung, Gabriel
    [J]. QUALITY OF LIFE RESEARCH, 2012, 21 : 61 - 61
  • [5] Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis
    Veenstra, D. L.
    Spackman, D. E.
    Bisceglie, A.
    Kowdley, K. V.
    Gish, R. G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1240 - 1252
  • [6] The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4
    Kamal, S. M.
    Kassim, S.
    EL Gohary, E.
    Fouad, A.
    Nabegh, L.
    Hafez, T.
    Bahnasy, K.
    Hassan, H.
    Ghoraba, D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 307 - 318
  • [7] Cost-effectiveness of treatment for chronic hepatitis C
    Koff, RS
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 : 255 - 258
  • [8] Cost-effectiveness of viral hepatitis B & C treatment
    Toy, Mehlika
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2013, 27 (06) : 973 - 985
  • [9] Cost-Effectiveness Analysis of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants
    Yakubu, I.
    Zhang, Y.
    Ijioma, S.
    Carroll, N. V.
    Patterson, J.
    Sterling, R.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 483 - 483
  • [10] THE COST EFFECTIVENESS ANALYSIS OF THE ORAL ANTI-VIRAL TREATMENTS ALTERNATIVES FOR THE CHRONIC HEPATITIS B IN TURKEY
    Kockaya, G.
    Kose, A.
    Dalgic, C.
    Yenilmez, F. B.
    Ozdemir, O.
    Kucuksayrac, E.
    Tayfun, K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A367 - A367
12345